38 results on '"Kourelis, Taxiarchis V."'
Search Results
2. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
3. Gastrointestinal amyloidosis: an often unexpected finding with systemic implications
4. Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
5. Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
6. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases
7. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center
8. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
9. IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis
10. Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma
11. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy
12. A Proteomic Atlas of Cardiac Amyloid Plaques
13. Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients
14. Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation
15. Utility of serum free light chain ratio in response definition in patients with multiple myeloma
16. Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy
17. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved
18. Impact of acquired del(17p) in multiple myeloma
19. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma
20. Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis
21. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing
22. Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy
23. Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma
24. Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma
25. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
26. Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis
27. Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
28. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
29. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
30. Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis
31. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies
32. Tc2 Response at the Onset of COPD Exacerbations
33. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis
34. Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75
35. MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM)
36. Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM)
37. Trisomy 8 as the sole cytogenetic abnormality in an adult patient with acute lymphoblastic leukemia
38. Defective Peripheral Blood Endothelial Cell Progenitors in Patients with Scleroderma and Psoriatic Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.